Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: 2019-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,320,031
Percent of class
10.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000460
Form type
SC 13G
Filer
ProQR Therapeutics N.V.
CIK
CIK 1612940
Filed
Nov 08, 2019
Reporting period
Oct 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub